Vascular dementia is the second-most common form of dementia after Alzheimer’s. About 2.7 million people in the U.S. are ...

A new pill for treating dementia is delivering promising "topline" results in early-stage clinical trials, according to a ...

Diabetes and weight loss drug semaglutide has been trialled in people with Alzheimer's. We explain what it means for dementia ...

For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...

The following guide offers a detailed overview of several classes of medications that research links to a higher risk of ...

New data raise the question of whether statins increase cardiovascular or cerebrovascular hospitalizations in dementia, but ...

Research conducted by the University of Cambridge and the University of Exeter examined large datasets to uncover correlations between medications and cognitive health. The findings suggest that ...

For the millions of people worldwide living with dementia, medication management presents unique challenges. While certain drugs help manage symptoms and slow cognitive decline, others can ...

On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, ...

Emerging evidence suggests there may be a critical window for estrogen therapy to protect against cognitive decline later in ...

During certain times of the day, some people with dementia may become more confused and disoriented. Referred to by ...